Cite

HARVARD Citation

    Hague, C. et al. (2016). Early Real Life Experience of Radium 223 (Ra223) in Castrate Resistant Prostate Cancer (CRPC). Clinical oncology. 28 (5), pp. e11-. [Online]. 
  
Back to record